- Diagnostic Différentiel
Drug Information for PHOTOFRIN (porfimer sodium) for Injection (Axcan Scandipharm Inc.): HOW SUPPLIED
- Clinical Studies
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Liens externes liés à PHOTOFRIN (porfimer sodium) for Injection (Axcan Scandipharm Inc.)
PHOTOFRIN® (porfimer sodium) for Injection is supplied as a freeze-dried cake or powder as follows:
NDC 58914-155-75 — 75 mg vial
PHOTOFRIN® freeze-dried cake or powder should be stored at Controlled Room Temperature 20−25°C (68−77°F) [see USP].
Spills and Disposal
Spills of PHOTOFRIN® should be wiped up with a damp cloth. Skin and eye contact should be avoided due to the potential for photosensitivity reactions upon exposure to light; use of rubber gloves and eye protection is recommended. All contaminated materials should be disposed of in a polyethylene bag in a manner consistent with local regulations.
PHOTOFRIN® is neither a primary ocular irritant nor a primary dermal irritant. However, because of its potential to induce photosensitivity, PHOTOFRIN® might be an eye and/or skin irritant in the presence of bright light. It is important to avoid contact with the eyes and skin during preparation and/or administration. As with therapeutic overdosage, any overexposed person must be protected from bright light.
WYETH-AYERST LEDERLE PARENTERALS, INC.
Carolina, Puerto Rico 00987
Axcan Scandipharm Inc.
Birmingham, AL 35242
For inquiries call Axcan Scandipharm Inc. at:
September 29, 2005
- Drug Information Provided by National Library of Medicine (NLM).